Viomycin sulfate is a tuberactinomycin antibiotic historically used in combination therapy to treat drug-resistant infections caused by Mycobacterium tuberculosis. This cyclic peptide agent functions by… Read more
Viomycin sulfate is a tuberactinomycin antibiotic historically used in combination therapy to treat drug-resistant infections caused by Mycobacterium tuberculosis. This cyclic peptide agent functions by binding to the bacterial ribosome, effectively inhibiting protein synthesis and disrupting essential cellular processes in susceptible pathogens. Within this category, researchers and pharmaceutical laboratories can access a specialized selection of reference standards, including the parent compound, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are critical for comprehensive analytical testing, facilitating accurate impurity profiling, precise method validation, and rigorous quality control protocols during pharmaceutical development. By ensuring the availability of these specific related compounds, laboratories can maintain regulatory compliance and support the integrity of their analytical assays for this potent anti-tubercular agent.